Cytokine Storm of SARS-CoV-2, the Virus that Causes COVID-19
##plugins.themes.bootstrap3.article.main##
The ongoing pandemic of COVID-19 has spread to the entire globe and is a public health emergency of international concern. The clinical picture of the disease is seen to be related to previously encountered beta-coronaviruses i.e. SARS-CoV and MERS-CoV. Most common symptoms include fever and cough and less commonly diarrhea, myalgias, nausea, sputum production. Still, other patients can present with multi-organ failure. Mortality risk is related to patient’s age and comorbidities. Laboratory and radiologic investigations are crucial for diagnosis and monitoring the prognosis of patients. The pathophysiology of COVID-19 is related to pulmonary inflammation and lung damage caused by the cytokine storm induced by local infection in the lung alveolar space. The cytokine storm is evident from an increase in the amount of several cytokines like IL1B, IL6, IL7, IL8, IL9, IL10, TNF, an INFγ. At present, a proper treatment for COVID-19 is unavailable. However, supportive care is being given to patients with anti-viral, anti-inflammatory, anti-bacterial, anti-fungal and artificial oxygen respiration. This paper focuses on the cytokine storm observed following SARS-CoV-2 infection and the current treatment strategies for the infection.
Downloads
References
-
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., … Yu, T. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 395(10223), 507–513. https://doi.org/10.1016/S0140-6736(20)30211-7
DOI | Google Scholar
1
-
Guan, W., Ni, Z., Hu, Y., Liang, W., Ou, C., He, J., … Zhong, N. (2020). Clinical characteristics of 2019 novel coronavirus infection in China. MedRxiv. https://doi.org/10.1101/2020.02.06.20020974
DOI | Google Scholar
2
-
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., … Gu, X. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
DOI | Google Scholar
3
-
ICTV. (2018). Virus Taxonomy: 2018 Release ICTV.
Google Scholar
4
-
Liu, F., Xu, A., Zhang, Y., Xuan, W., Yan, T., Pan, K., … Zhang, J. (2020). Patients of COVID-19 may benefit from sustained lopinavir-combined regimen. International Journal of Infectious Diseases, 4019. https://doi.org/10.1016/j.ijid.2020.03.013
DOI | Google Scholar
5
-
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020). COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet, 6736(20), 19–20. https://doi.org/10.1016/ S0140-6736(20)30628-0
DOI | Google Scholar
6
-
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012). Into the Eye of the Cytokine Storm. 16–32. https://doi.org/10.1128/MMBR.05015-11
DOI | Google Scholar
7
-
Wang, D., Bo, H., Chang, H. (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA, 323(11), 1061-1069. https://doi.org/ 10.1001/jama.2020.1585
DOI | Google Scholar
8
-
Xiaohua, C., Binhong, Z., Yueming, Q., Yurou, C., Jie, X., Yong, F., …Feng, L. Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely associated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients. MedRxiv. https://doi.org/10.1101/2020.02.29.20029520
DOI | Google Scholar
9
-
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., … Wang, Y. (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet 2600(20), 1–7. https://doi.org/10.1016/S2213-2600(20)30079-5
DOI | Google Scholar
10
Most read articles by the same author(s)
-
Hassan S. Naji,
Dengue Fever and Global Warming: An Epidemiological Analysis , European Journal of Medical and Health Sciences: Vol. 5 No. 5 (2023) -
Hassan S. Naji,
The Emerging of The 2019 Novel Coronavirus 2019-nCoV , European Journal of Medical and Health Sciences: Vol. 2 No. 1 (2020) -
Hassan S. Naji,
Oleothorax: Review of Literature; Report of a Case Study and a Potential Treatment for Multi-Resistant Tuberculosis (MRTB) , European Journal of Medical and Health Sciences: Vol. 1 No. 3 (2019) -
Hassan S. Naji,
The Role of Calorie Restriction in Cancer Prevention, Cancer Treatment, Longevity, and in Reducing Cellular Stress , European Journal of Medical and Health Sciences: Vol. 5 No. 6 (2023) -
Hassan S. Naji,
Clinical Characterization of COVID-19 , European Journal of Medical and Health Sciences: Vol. 2 No. 2 (2020) -
Hassan S. Naji,
Hepatic and Cardiac Complications Related to Zika Virus Infection , European Journal of Medical and Health Sciences: Vol. 1 No. 2 (2019) -
Hassan S. Naji,
Cardiovascular Complications Associated with COVID-19 Infection , European Journal of Medical and Health Sciences: Vol. 2 No. 4 (2020)